Denis Bedoret
Vorstandsvorsitzender bei ImCyse SA
Profil
Denis Bedoret is currently the Chief Executive Officer & Director at ImCyse SA, Director at Exothera SA, and Director at Ncardia Holding SA. He previously worked as the General Manager-Masthercell at Orgenesis, Inc., General Manager at MaSTherCell SA, and President at Catalent MSTC, Inc. He received his undergraduate and doctorate degrees from the University of Liege.
Aktive Positionen von Denis Bedoret
| Unternehmen | Position | Beginn |
|---|---|---|
ImCyse SA
 ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Vorstandsvorsitzender | 01.09.2020 |
Exothera SA
 Exothera SA Chemicals: SpecialtyProcess Industries Exothera SA is a Belgian company that manufactures and develops viral vector and nucleic acid. The private company is based in Jumet, Belgium. The company was founded in 2020 by José Fernandez Castillo, Hugues Bultot. The CEO is Thibault Jonckheere. | Direktor/Vorstandsmitglied | 21.09.2020 |
Ncardia Holding SA
 Ncardia Holding SA BiotechnologyHealth Technology Ncardia Holding SA provides biotech research and development, business management consulting, technical testing, and administrative services. The private company is based in Mont-Saint-Guibert, Belgium. The Belgian company was founded in 2014. Stefan Braam has been the CEO of the company since 2015. | Direktor/Vorstandsmitglied | 11.11.2021 |
Ehemalige bekannte Positionen von Denis Bedoret
| Unternehmen | Position | Ende |
|---|---|---|
| ORGENESIS INC. | Corporate Officer/Principal | - |
Catalent MSTC, Inc.
 Catalent MSTC, Inc. Medical SpecialtiesHealth Technology Catalent MSTC, Inc. provides full service contract development and manufacturing services (CDMO) for cell therapy companies. It offers process and assay development, quality management, and cGMP cell therapy manufacturing services. The company was incorporated on December 27, 2017 and is headquartered in Dover, DE. | Präsident | - |
MaSTherCell SA
 MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium. | Vorstandsvorsitzender | - |
Ausbildung von Denis Bedoret
| University of Liege | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ORGENESIS INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Health Technology |
MaSTherCell SA
MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium. | Health Technology |
Catalent MSTC, Inc.
Catalent MSTC, Inc. Medical SpecialtiesHealth Technology Catalent MSTC, Inc. provides full service contract development and manufacturing services (CDMO) for cell therapy companies. It offers process and assay development, quality management, and cGMP cell therapy manufacturing services. The company was incorporated on December 27, 2017 and is headquartered in Dover, DE. | Health Technology |
Exothera SA
Exothera SA Chemicals: SpecialtyProcess Industries Exothera SA is a Belgian company that manufactures and develops viral vector and nucleic acid. The private company is based in Jumet, Belgium. The company was founded in 2020 by José Fernandez Castillo, Hugues Bultot. The CEO is Thibault Jonckheere. | Process Industries |
Ncardia Holding SA
Ncardia Holding SA BiotechnologyHealth Technology Ncardia Holding SA provides biotech research and development, business management consulting, technical testing, and administrative services. The private company is based in Mont-Saint-Guibert, Belgium. The Belgian company was founded in 2014. Stefan Braam has been the CEO of the company since 2015. | Health Technology |
